Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Antibody Identification - II

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 50

Blood Group Antibody Identification

Jim Perkins, M.D.


NorthShore University Health System Blood Banks
2006, James T. Perkins, all rights reserved

Results which prompt ABID Initial identification tests Analyzing a panel (forming a hypothesis) Confirmatory tests:
Rule out cells Rule in cells Antigen typing Elution/adsorption Neutralization tests
06, James T. Perkins

Standard test results: Normal Person


Forward and Reverse ABO types match

Antibody screen negative


Crossmatch is negative with ABO

compatible RBCs
(Direct Antiglobulin Test negative)
06, James T. Perkins

Identify cause of abnormality when:


Antibody screen is positive
Forward and reverse ABO typing dont match Crossmatch positive; negative antibody screen

(Positive DAT)
06, James T. Perkins

Typical problem
<A <B A cells B cells >D Interpretation

+
37o, 30

O Pos

IS OI OII

AHG

CC

Interpretation

0 0

0 0

0 3+

2+ Positive NT
06, James T. Perkins

Initial ABID Tests


ABID panel
Same IAT technique as antibody screen

DAT More specimen Patient history


What is the urgency of transfusion? Has the patient been pregnant or transfused? Is there an autoimmune disease?
06, James T. Perkins

Antibody Identification panel D 1 + 2 + 3 + C + + 0 c 0 0 + E 0 0 + e + + 0 K + 0 + k + + + S 0 0 + s + + 0 AHG 0 0 3+

4 +
5 0 6 0 7 0 8 0

0
0 0 0 0

+
+ + + +

+
0 0 0 +

0
+ + + +

0
0 + 0 0

+
+ + + +

+
0 0 + 0

+
+ + + +

3+
0 0 0 2+
06, James T. Perkins

Analyzing a panel
Crossout all antigens NON-REACTIVE in double dose

Corresponding ANTIBODIES are ruled out


06, James T. Perkins

C+c- (C/C) Double dose C

C+c+ (C/c) Single dose C


06, James T. Perkins

D
1 +

C
+

c
0

E
0

e
+

K
+

k
+

S
0

s
+

AHG
0

2
3 4 5 6 7 8

+
+ + 0 0 0 0

+
0 0 0 0 0 0

0
+ + + + + +

0
+ + 0 0 0 +

+
0 0 + + + +

0
+ 0 0 + 0 0

+
+ + + + + +

0
+ + 0 0 + 0

+
0 + + + + +

0
3+ 3+ 0 0 0 2+

06, James T. Perkins

D
1 +

C
+

c
0

E
0

e
+

K
+

k
+

S
0

s
+

AHG
0

2
3 4 5 6 7 8

+
+ + 0 0 0 0

+
0 0 0 0 0 0

0
+ + + + + +

0
+ + 0 0 0 +

+
0 0 + + + +

0
+ 0 0 + 0 0

+
+ + + + + +

0
+ + 0 0 + 0

+
0 + + + + +

0
3+ 3+ 0 0 0 2+

06, James T. Perkins

D
1 +

C
+

c
0

E
0

e
+

K
+

k
+

S
0

s
+

AHG
0

2
3 4 5 6 7 8

+
+ + 0 0 0 0

+
0 0 0 0 0 0

0
+ + + + + +

0
+ + 0 0 0 +

+
0 0 + + + +

0
+ 0 0 + 0 0

+
+ + + + + +

0
+ + 0 0 + 0

+
0 + + + + +

0
3+ 3+ 0 0 0 2+

06, James T. Perkins

D
1 +

C
+

c
0

E
0

e
+

K
+

k
+

S
0

s
+

AHG
0

2
3 4 5 6 7 8

+
+ + 0 0 0 0

+
0 0 0 0 0 0

0
+ + + + + +

0
+ + 0 0 0 +

+
0 0 + + + +

0
+ 0 0 + 0 0

+
+ + + + + +

0
+ + 0 0 + 0

+
0 + + + + +

0
3+ 3+ 0 0 0 2+

06, James T. Perkins

D
1 +

C
+

c
0

E
0

e
+

K
+

k
+

S
0

s
+

AHG
0

2
3 4 5 6 7 8

+
+ + 0 0 0 0

+
0 0 0 0 0 0

0
+ + + + + +

0
+ + 0 0 0 +

+
0 0 + + + +

0
+ 0 0 + 0 0

+
+ + + + + +

0
+ + 0 0 + 0

+
0 + + + + +

0
3+ 3+ 0 0 0 2+

06, James T. Perkins

D
1 +

C
+

c
0

E
0

e
+

K
+

k
+

S
0

s
+

AHG
0

2
3 4 5 6 7 8

+
+ + 0 0 0 0

+
0 0 0 0 0 0

0
+ + + + + +

0
+ + 0 0 0 +

+
0 0 + + + +

0
+ 0 0 + 0 0

+
+ + + + + +

0
+ + 0 0 + 0

+
0 + + + + +

0
3+ 3+ 0 0 0 2+

06, James T. Perkins

D
1 +

C
+

c
0

E
0

e
+

K
+

k
+

S
0

s
+

AHG
0

2
3 4 5 6 7 8

+
+ + 0 0 0 0

+
0 0 0 0 0 0

0
+ + + + + +

0
+ + 0 0 0 +

+
0 0 + + + +

0
+ 0 0 + 0 0

+
+ + + + + +

0
+ + 0 0 + 0

+
0 + + + + +

0
3+ 3+ 0 0 0 2+

06, James T. Perkins

D
1 +

C
+

c
0

E
0

e
+

K
+

k
+

S
0

s
+

AHG
0

2
3 4 5 6 7 8

+
+ + 0 0 0 0

+
0 0 0 0 0 0

0
+ + + + + +

0
+ + 0 0 0 +

+
0 0 + + + +

0
+ 0 0 + 0 0

+
+ + + + + +

0
+ + 0 0 + 0

+
0 + + + + +

0
3+ 3+ 0 0 0 2+

06, James T. Perkins

D
1 +

C
+

c
0

E
0

e
+

K
+

k
+

S
0

s
+

AHG
0

2
3 4 5 6 7 8

+
+ + 0 0 0 0

+
0 0 0 0 0 0

0
+ + + + + +

0
+ + 0 0 0 +

+
0 0 + + + +

0
+ 0 0 + 0 0

+
+ + + + + +

0
+ + 0 0 + 0

+
0 + + + + +

0
3+ 3+ 0 0 0 2+

06, James T. Perkins

Hypothesis
The positive antibody screen was due to anti-E
Anti-E explains all of the reactions. (Note dosage effect)
06, James T. Perkins

When is the hypothesis regarding the antibody specificityProved?


1. 3 antigen positive cells are reactive 2. 3 antigen negative cells are non-reactive 3. Clinically significant and common antibodies are ruled out
Rh (anti-D, -C, -c, -E, -e) Duffy (anti-Fya, -Fyb) MNSs (anti-M, -N, -S, -s) P system (anti-P1) Kell (anti-K, -k) Kidd (anti-Jka, -Jkb) Lewis (anti-Lea, -Leb)

4. The patient LACKS the corresponding antigen


06, James T. Perkins

D
1 +

C
+

c
0

E
0

e
+

K
+

k
+

S
0

s
+

AHG
0

2
3 4 5 6 7 8

+
+ + 0 0 0 0

+
0 0 0 0 0 0

0
+ + + + + +

0
+ + 0 0 0 +

+
0 0 + + + +

0
+ 0 0 + 0 0

+
+ + + + + +

0
+ + 0 0 + 0

+
0 + + + + +

0
3+ 3+ 0 0 0 2+

06, James T. Perkins

Need to rule out anti-S Rule-out cells are NON-reactive cells

D
+

C
+

c
0

E
0

e
+

K
+

k
+

S
+

s
0

AHG
0
06, James T. Perkins

Antigen Typing
Hypothesis: ALLO-anti-E

Patient

CC

Pos Neg control control


4+ 0

CC

Anti-E

2+

2+

06, James T. Perkins

Immunohematologic diagnosis: alloanti-E


1. 2. 3. 3 E positive cells are reactive 3 E negative cells are non-reactive The following antibodies are ruled out
Rh (anti-D, -C, -c, -e) Duffy (anti-Fya, -Fyb) MNSs (anti-M, -N, -S, -s) P system (anti-P1) Kell (anti-K, -k) Kidd (anti-Jka, -Jkb) Lewis (anti-Lea, -Leb)

4.

The patient LACKS the E antigen


06, James T. Perkins

D
1 +

C
+

c
0

E
0

e
+

K
+

k
+

S
0

s
+

AHG
4+

2
3 4 5 6 7 8

+
+ + 0 0 0 0

+
0 0 0 0 0 0

0
+ + + + + +

0
+ + 0 0 0 +

+
0 0 + + + +

0
0 + 0 + 0 0

+
+ + + + + +

0
+ + 0 0 + 0

+
0 + + + + +

4+
0 3+ 0 3+ 0 0

06, James T. Perkins

Hypothesis: anti-C plus anti-K


Need to RULE IN both antibodies

Rule-in cells are REACTIVE cells


D + + 0 C + + 0 c 0 0 + E 0 0 0 e + + + K 0 0 + k + + + S 0 0 0 s + + + AHG 4+ 4+ 3+
06, James T. Perkins

Antigen Typing
Hypothesis: ALLO-anti-C and -anti-K

Patient

CC

Pos Neg control control 4+ 0

CC

Anti-C

2+

2+

Anti-K

2+

4+

2+
06, James T. Perkins

D
1 +

C
+

c
0

E
0

e
+

K
+

k
+

S
0

s
+

AHG
4+

2
3 4 5 6 7 8

+
+ + 0 0 0 0

+
0 0 0 0 0 0

0
+ + + + + +

0
+ + 0 0 0 +

+
0 0 + + + +

0
+ 0 0 + 0 0

+
+ + + + + +

0
+ 0 0 0 + 0

+
0 + + + + +

4+
0 0 4+ 4+ 4+ 4+

06, James T. Perkins

Antigen Typing
Hypothesis: ALLO-anti-e Cant rule out: anti-C Patient Anti-C Anti-e 3+ 0 CC NT 2+ Pos Neg control control 4+ 4+ 0 0 CC 2+ 2+

Conclusion: anti-C ruled out


06, James T. Perkins

What if the DAT was positive?


Detects: In vivo sensitization by antibody or complement Autoimmune Hemolytic Anemia Hemolytic Transfusion Reaction Hemolytic Disease of Newborn Drug/RBC Antibodies Passive Immunization (esp. plts.)
06, James T. Perkins

Application:

Consider the following test results:


Group O, Rh positive
Antibody screen positive

Antibody identification; serum anti-e


Direct antiglobulin test positive

The patient HAS the e antigen (not


transfused)
06, James T. Perkins

DAT

Poly

Anti-IgG

Anti-C3 O
e+ e+

Eluate

e+
ee-

Conclusion: Auto-anti-e
06, James T. Perkins

Autoanti-e in serum and eluate.


D + C + c 0 E 0 e + K + k + S 0 s + Serum Eluate 2+ 3+

+ + +
0 0 0 0

+ 0 0
0 0 0 0

0 + +
+ + + +

0 + +
0 0 0 +

+ 0 0
+ + + +

0 + 0
0 + 0 0

+ + +
+ + + +

0 + +
0 0 + 0

+ 0 +
+ + + +

2+ 0 0
2+ 2+ 2+ 2+

3+ 1+ 1+
3+ 3+ 3+ 3+
06, James T. Perkins

Most Autoantibodies are Pan-agglutinins


D + C + c 0 E 0 e + K + k + S 0 s + Serum Eluate 2+ 3+

+ + +
0 0 0 0

+ 0 0
0 0 0 0

0 + +
+ + + +

0 + +
0 0 0 +

+ 0 0
+ + + +

0 + 0
0 + 0 0

+ + +
+ + + +

0 + +
0 0 + 0

+ 0 +
+ + + +

2+ 2+ 2+
2+ 2+ 2+ 2+

3+ 3+ 3+
3+ 3+ 3+ 3+
06, James T. Perkins

Auto-antibody can mask allo-antibody


D C c E e K k S s Autoab AntiK

+ +
+ + 0 0 0 0

+ +
0 0 0 0 0 0

0 0
+ + + + + +

0 0
+ + 0 0 0 +

+ +
0 0 + + + +

+ 0
+ 0 0 + 0 0

+ +
+ + + + + +

0 0
+ + 0 0 + 0

+ +
0 + + + + +

4+ 4+
4+ 4+ 4+ 4+ 4+ 4+

1+ 0
1+ 0 0 1+ 0 0
06, James T. Perkins

Auto-antibody + Allo-antibody

06, James T. Perkins

Separate serum and RBCs

06, James T. Perkins

Remove auto-antibody from the RBCs

ZZAP: DTT

Papain
PBS Chloroquine
06, James T. Perkins

Return serum to the RBCs

06, James T. Perkins

Incubate

06, James T. Perkins

Separate again

Adsorbed serum
06, James T. Perkins

Autoadsorbed serum may reveal an underlying ab


D C c E e K k S s Raw Ads Serum serum

+
+ + + 0 0 0 0

+
+ 0 0 0 0 0 0

0
0 + + + + + +

0
0 + + 0 0 0 +

+
+ 0 0 + + + +

+
0 + 0 0 + 0 0

+
+ + + + + + +

0
0 + + 0 0 + 0

+
+ 0 + + + + +

2+
2+ 2+ 2+ 2+ 2+ 2+ 2+

1+
0 1+ 0 0 1+ 0 0
06, James T. Perkins

Neutralizable Antibody

06, James T. Perkins

Neutralization Test

incubate

06, James T. Perkins

Neutralization may demonstrate allo-ab specificity


D C c E e K k Lea Leb Raw serum HPC neut.

+ +
+ + 0 0 0 0

+ +
0 0 0 0 0 0

0 0
+ + + + + +

0 0
+ + 0 0 0 +

+ +
0 0 + + + +

+ 0
+ 0 0 + 0 0

+ +
+ + + + + +

0 +
0 0 0 0 + 0

+ 0
+ + + 0 0 +

0 0
1+ 0 0 0 0 0

0 0
0 0 0 0 0 0
06, James T. Perkins

Neutralized serum may reveal an underlying ab


D C c E e K k Lea Leb Raw Neut. serum serum

+ +
+ + 0 0 0 0

+ +
0 0 0 0 0 0

0 0
+ + + + + +

0 0
+ + 0 0 0 +

+ +
0 0 + + + +

+ 0
+ 0 0 + 0 0

+ +
+ + + + + +

0 +
0 0 0 0 + 0

+ 0
+ + + 0 0 +

2+ 0
3+ 3+ 2+ 0 0 3+

0 0
3+ 3+ 0 0 0 3+
06, James T. Perkins

ABO discrepancy
<A <B A cells B cells >D Interpretation

4+

1+
37o, 30

4+

3+

IS OI OI

AHG

CC

Interpretation

1+ 0

W+ 0

0 0

2+ 2+

Positive (? ab)
06, James T. Perkins

Antibody against a low-frequency antigen D 1 + 2 + 3 + C + + 0 c 0 0 + E 0 0 + e + + 0 K + 0 + k + + + S 0 0 + s + + 0 AHG 0 0 0

4 +
5 0

0
0

+
+

+
0

0
+

0
0

+
+

+
0

+
+

3+
0

6 0
7 0 8 0

0
0 0

+
+ +

0
0 +

+
+ +

+
0 0

+
+ +

0
+ 0

+
0 +

0
0 0
06, James T. Perkins

Antibody against a high-frequency antigen D 1 + 2 + 3 + C + + 0 c 0 0 + E 0 0 + e + + 0 K + 0 + k + + + S 0 0 + s + + 0 AHG 3+ 3+ 3+

4 +
5 0

0
0

+
+

+
0

0
+

0
0

+
+

+
0

+
+

3+
3+

6 0
7 0 AC

0
0

+
+

0
0

+
+

+
0

+
+

0
+

+
0

3+
3+ 0
06, James T. Perkins

(Patient cells + patient serum)

Key question: Does my answer explain all of the reactions?

06, James T. Perkins

You might also like